That is the news we need next tuesday. After good reported data yesterday we need this follow through badly to gain market support. I believe we get it and Punit realizes this is critical and has said we are going into the registration trial with a drug supply partnership. Oncosec Game Face on next Tuesday! Let's get this done and fast.
Okay. Yes that would send a positive message to the medical community of Merck's endorsement for the $ONCS registered clinical trial using $ONCS EP+IL12 on the Keytruda non-responders.
$ONCS is also looking for a Partnership that would pay for the entire anti-PD1 registered trial.